BB&T Securities LLC increased its position in shares of Clorox Company (The) (NYSE:CLX) by 32.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,746 shares of the company’s stock after buying an additional 2,393 shares during the period. BB&T Securities LLC’s holdings in Clorox Company (The) were worth $1,298,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in CLX. Crossvault Capital Management LLC increased its stake in Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock worth $4,676,000 after buying an additional 1,285 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock worth $146,932,000 after buying an additional 25,110 shares in the last quarter. Geode Capital Management LLC increased its stake in Clorox Company (The) by 4.3% in the first quarter. Geode Capital Management LLC now owns 1,247,940 shares of the company’s stock worth $168,019,000 after buying an additional 51,563 shares in the last quarter. Destination Wealth Management increased its stake in Clorox Company (The) by 14.0% in the first quarter. Destination Wealth Management now owns 30,225 shares of the company’s stock worth $4,075,000 after buying an additional 3,716 shares in the last quarter. Finally, Janney Capital Management LLC bought a new stake in Clorox Company (The) during the first quarter worth approximately $216,000. Institutional investors and hedge funds own 69.83% of the company’s stock.
Shares of Clorox Company (NYSE:CLX) opened at 137.48 on Friday. Clorox Company has a one year low of $111.24 and a one year high of $141.76. The firm has a 50 day moving average price of $134.18 and a 200 day moving average price of $134.70. The company has a market capitalization of $17.74 billion, a P/E ratio of 25.77 and a beta of 0.40.
Clorox Company (The) (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the business posted $1.30 earnings per share. Clorox Company (The)’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities research analysts predict that Clorox Company will post $5.67 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Clorox Company (The) (CLX) Position Raised by BB&T Securities LLC” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://stocknewstimes.com/2017/08/27/clorox-company-the-clx-position-raised-by-bbt-securities-llc.html.
A number of equities research analysts recently commented on CLX shares. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 price objective (up previously from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. BMO Capital Markets reiterated a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a report on Thursday, May 4th. Royal Bank Of Canada reiterated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Finally, BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus target price of $129.05.
In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.
About Clorox Company (The)
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.
